Does Lipo 360 Improve Health? What the Evidence Shows

Apr 18

Lipo 360 should not be expected to improve heart health or treat metabolic disease. It removes subcutaneous fat around the torso, not the visceral fat surrounding the internal organs that is more strongly associated with cardiometabolic risk. Research on blood pressure, cholesterol, inflammation, and insulin sensitivity after liposuction is mixed, and the best evidence does not establish liposuction as a cardiovascular or weight-loss treatment. Its proven purpose is body contouring.

Key Takeaways

Lipo 360 removes selected subcutaneous fat from the abdomen, waist, flanks, and back. It cannot directly remove visceral fat inside the abdominal cavity.
A landmark controlled metabolic study found that major subcutaneous fat removal did not significantly improve insulin sensitivity, blood pressure, glucose, lipids, or inflammatory markers.
Later studies have reported some favorable metabolic changes, but results are inconsistent and some effects appear temporary.
A randomized trial found increased visceral fat six months after abdominal liposuction in participants who did not exercise, while the exercise group avoided that increase.
If your goal is lower cardiovascular risk, Lipo 360 should not replace evidence-based weight management, physical activity, nutrition, blood-pressure control, lipid management, diabetes care, or other medical treatment.

Does Lipo 360 improve your health?

Not in a way that should be promised clinically. Lipo 360 is circumferential liposuction used to reshape the abdomen, waist, flanks, and lower back. It can reduce the thickness of pinchable subcutaneous fat and change body proportions, but a smaller waist after surgery is not the same thing as a proven reduction in cardiovascular disease risk.

This distinction has been studied for more than two decades. The question is scientifically interesting because excess abdominal fat is associated with metabolic disease, but different fat compartments behave differently. Liposuction removes one compartment while leaving the deeper visceral compartment largely untouched.

Question	What the evidence supports	What should not be promised
Does Lipo 360 remove abdominal fat?	Yes. It removes selected subcutaneous fat accessible beneath the skin.	That every type of abdominal fullness will disappear.
Does it remove visceral fat?	No. Visceral fat lies inside the abdominal cavity around the organs.	That liposuction treats the metabolically important internal fat depot.
Does it improve insulin resistance?	Studies are mixed. Some report changes, while rigorous trials have found no meaningful improvement.	That liposuction treats insulin resistance, prediabetes, or diabetes.
Does it lower cholesterol or blood pressure?	Some studies report short-term changes, but effects are inconsistent and may not persist.	That Lipo 360 is a treatment for hypertension or dyslipidemia.
Does it reduce heart-disease risk?	No established cardiovascular-risk reduction has been demonstrated.	That the procedure is “heart healthy.”
Can lifestyle after surgery matter?	Yes. Physical activity, nutrition, and weight stability affect visceral fat and cardiometabolic health independently of liposuction.	That surgery itself deserves credit for benefits created by later lifestyle changes.

Why does the difference between subcutaneous and visceral fat matter?

Subcutaneous fat sits beneath the skin and above the abdominal wall. This is the layer a liposuction cannula can access. Visceral fat is deeper, inside the abdominal cavity, surrounding internal organs. The two compartments are related to health differently.

The American Society of Plastic Surgeons specifically notes that liposuction targets subcutaneous fat and does not remove intra-abdominal visceral fat. ASPS guidance on common liposuction misconceptions also emphasizes that liposuction is a contouring procedure rather than a weight-loss treatment.

This matters visually too. A patient can have relatively little pinchable abdominal fat but still have a firm, projecting abdomen because much of the fullness lies behind the abdominal wall. Removing more superficial fat cannot safely reach that internal compartment.

Practical distinction: Lipo 360 can make the outer contour smaller without necessarily changing the internal metabolic fat burden that contributed to cardiovascular risk in the first place.

What did the landmark metabolic study find after large-volume liposuction?

A frequently cited New England Journal of Medicine study examined 15 women with abdominal obesity before and 10 to 12 weeks after large-volume abdominal liposuction. Some participants had normal glucose tolerance and others had type 2 diabetes. The procedure removed a substantial amount of subcutaneous abdominal fat.

Despite that large reduction, the investigators found no significant improvement in insulin sensitivity in the liver, skeletal muscle, or adipose tissue. They also found no significant improvement in blood pressure, fasting glucose, insulin, lipid concentrations, C-reactive protein, interleukin-6, tumor necrosis factor alpha, or adiponectin. The NEJM study on abdominal liposuction and coronary risk factors concluded that simply removing a large amount of subcutaneous fat did not reproduce the metabolic benefits of conventional weight loss.

That study was small, so it should not be treated as the final word on every metabolic marker. But it directly tested the assumption that mechanically removing abdominal fat would function like metabolic weight loss, and it did not support that assumption.

Why do some studies report metabolic improvements after liposuction?

The literature is genuinely mixed. Studies differ in the amount of fat removed, patient BMI, baseline insulin resistance, follow-up duration, whether weight changed after surgery, and how metabolic outcomes were measured. Those differences can produce apparently conflicting results.

A 2022 dose-response meta-analysis combined 22 studies involving 493 participants. It reported improvements in several markers, including fasting insulin and insulin resistance, after surgical fat removal. It also found short-term reductions in body mass index, fat mass, waist circumference, leptin, tumor necrosis factor alpha, cholesterol, and blood pressure. Importantly, many of the peak changes occurred early and moved back toward preoperative levels by about postoperative day 180. The meta-analysis of metabolic changes after surgical fat removal therefore does not justify calling liposuction a durable metabolic therapy.

Other systematic reviews have also described possible favorable changes in selected biomarkers while emphasizing inconsistent evidence and the need for better prospective research. That is why the scientifically accurate statement is not “liposuction has no biological effects.” It is that any metabolic effects observed so far are too inconsistent to use as the reason for offering Lipo 360 or to promise cardiovascular benefit to an individual patient.

Can liposuction affect visceral fat later?

One randomized controlled trial raises an important point about what happens after surgery. Thirty-six healthy normal-weight women underwent small-volume abdominal liposuction. Two months later, they were randomized to a four-month exercise program or no exercise program.

At six months, the group that did not exercise had a statistically significant increase of approximately 10% in visceral fat compared with baseline, while the exercise group did not. The randomized trial of visceral fat after liposuction concluded that the compensatory increase was counteracted by physical activity.

This was one study of 36 women after small-volume abdominal liposuction, so it would be wrong to claim that every patient gains visceral fat after surgery. The more useful lesson is that removing subcutaneous fat does not eliminate the biology of energy balance or make exercise irrelevant. Postoperative habits still matter greatly to internal fat and cardiometabolic health.

Can Lipo 360 motivate healthier habits?

It can motivate some people, but that indirect possibility should not be converted into a medical benefit of the operation itself. A patient may feel more comfortable exercising after recovery, become more attentive to weight maintenance, or use surgery as a personal milestone. Those behaviors can be valuable.

However, if improved nutrition or physical activity later lowers visceral fat, blood pressure, cholesterol, or glucose, the health benefit comes from those changes. The surgery should not receive causal credit without evidence that it independently produced the improvement.

The Adonis guide to lifestyle and nutrition around liposuction is the better place to plan habits that support recovery and long-term weight stability.

What health questions actually matter before Lipo 360?

There is another reason not to market Lipo 360 as a health intervention: it is still elective surgery. The health conversation before the procedure should focus first on whether the operation is appropriate and safe for that patient.

Medical history, cardiovascular disease, blood pressure, diabetes, previous blood clots, nicotine use, medications, anemia, pulmonary conditions, BMI, treatment extent, anesthesia, fluid shifts, and any combined procedures can change the surgical risk assessment. Circumferential treatment also involves more surface area than a small isolated liposuction procedure.

The Adonis article Is Liposuction Safe? covers complication rates, blood clots, fluid-related risks, and factors that can make larger-volume or multi-area procedures more complex.

Patients should also plan the postoperative period realistically. The Lipo 360 recovery timeline explains why swelling, compression, work, exercise, and final contour should be planned separately from any discussion of metabolic health.

What should you expect Lipo 360 to do?

A good indication is straightforward: you are near a reasonably stable weight, have localized subcutaneous fat around the midsection, have suitable skin quality, and want a circumferential contour change. In that setting, Lipo 360 can address the visible fat layer it was designed to treat.

It should not be presented as a treatment for obesity, visceral adiposity, metabolic syndrome, hypertension, abnormal cholesterol, insulin resistance, diabetes, or cardiovascular disease. Those conditions deserve evidence-based medical management and should be part of the preoperative health assessment when relevant.

If internal abdominal fat is a major contributor to a projecting abdomen, losing visceral fat through appropriate weight management can change both health and body shape in a way that liposuction cannot reproduce. Surgery can then be considered for residual subcutaneous contour concerns after weight is reasonably stable.

Honest limitation: research on the metabolic effects of liposuction is heterogeneous. Different studies have found neutral, favorable, and occasionally unfavorable changes in specific biomarkers. What has not been established is that Lipo 360 reduces cardiovascular events or should be prescribed to improve heart or metabolic health. The appropriate reason to consider the operation remains body contouring.

Frequently Asked Questions

Does Lipo 360 remove visceral fat?

No. Lipo 360 removes selected subcutaneous fat beneath the skin around the torso. Visceral fat lies deeper inside the abdominal cavity around the organs and is not accessible to a liposuction cannula. If visceral fat contributes significantly to abdominal projection, liposuction cannot directly remove that component.

Can Lipo 360 lower cholesterol?

Some studies have reported short-term reductions in total cholesterol after larger-volume liposuction, while others have found no meaningful change. Meta-analytic evidence suggests that some early metabolic changes may diminish over several months. Liposuction should therefore not be used as treatment for high cholesterol.

Can liposuction lower blood pressure?

Research is mixed. Some small studies have reported temporary decreases in blood pressure, while controlled studies have found no significant improvement. There is no established evidence that liposuction treats hypertension or reduces cardiovascular events. Blood-pressure management should continue according to the patient's medical care plan.

Does liposuction improve insulin resistance?

Studies disagree. Some report improvements in fasting insulin or insulin-resistance measures, while the landmark controlled metabolic study found no significant improvement despite removing a large amount of abdominal subcutaneous fat. Liposuction is not an accepted treatment for insulin resistance, prediabetes, or diabetes.

Can visceral fat increase after liposuction?

A small randomized trial found about a 10% increase in visceral fat six months after abdominal liposuction among participants who did not exercise, while an exercise group avoided that increase. That result should not be generalized to every patient, but it reinforces that physical activity and energy balance still matter after surgery.

Is Lipo 360 a weight-loss procedure?

No. Lipo 360 is a body-contouring procedure for selected subcutaneous fat around the torso. It is not intended to treat obesity or replace dietary, activity, behavioral, or medical approaches to weight management. Stronger candidates are generally near a stable weight and want to change localized contour rather than use surgery for general weight loss.

Choose Lipo 360 for contouring, not for a health claim

A consultation can determine whether your midsection concern is mainly subcutaneous fat, visceral fullness, loose skin, abdominal-wall anatomy, or a combination. The surgical team at Adonis Plastic Surgery can then explain what Lipo 360 can realistically change and whether another approach better matches your anatomy and health goals.

Request a Consultation

References

Adonis Plastic Surgery is located at 2557 Pacific Coast Highway in Torrance, California, serving patients across the South Bay including Redondo Beach, Palos Verdes, Manhattan Beach, El Segundo, San Pedro, Long Beach, Carson, and Gardena.

Medically reviewed by the surgical team at Adonis Plastic Surgery. Last updated September 2026.

Dr. Josh Jacobson

Dr. Joshua Jacobson is renowned for his expertise in body contouring and facial procedures. Trained at Albert Einstein/Montefiore Medical Center, Josh specializes in Brazilian buttock lifts, VASER liposuction, blepharoplasty, and breast enhancement surgeries. Known in West LA and Beverly Hills for his precise techniques and celebrity-quality results, Dr. Jacobson combines technical skills with genuine patient care, ensuring outstanding outcomes.